496 related articles for article (PubMed ID: 1709852)
41. An overview of the animal pharmacology of paroxetine.
Johnson AM
Acta Psychiatr Scand Suppl; 1989; 350():14-20. PubMed ID: 2530769
[TBL] [Abstract][Full Text] [Related]
42. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
Bascara L
Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
[No Abstract] [Full Text] [Related]
43. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
Laursen AL; Mikkelsen PL; Rasmussen S; le Fèvre Honoré P
Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
[TBL] [Abstract][Full Text] [Related]
44. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
[TBL] [Abstract][Full Text] [Related]
45. Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.
Hamilton TC; Norton J; Poyser RH; Thormählen D
Arzneimittelforschung; 1986 Mar; 36(3):460-3. PubMed ID: 2939838
[TBL] [Abstract][Full Text] [Related]
46. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
47. New antidepressants and 5-HT uptake inhibitors.
Montgomery SA
Acta Psychiatr Scand Suppl; 1989; 350():107-16. PubMed ID: 2530760
[TBL] [Abstract][Full Text] [Related]
48. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic effects of serotonin uptake inhibitors in depression.
Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
[TBL] [Abstract][Full Text] [Related]
50. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
Baldwin D; Bullock T; Montgomery D; Montgomery S
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
[TBL] [Abstract][Full Text] [Related]
51. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Murdoch D; McTavish D
Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of the selective serotonin reuptake inhibitors.
DeVane CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
[TBL] [Abstract][Full Text] [Related]
53. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
Mertens C; Pintens H
Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
[TBL] [Abstract][Full Text] [Related]
54. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
55. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
[No Abstract] [Full Text] [Related]
56. [Adverse effects: priapism caused by paroxetine].
Bertholon F; Krajewski Y; el Allali A
Ann Med Psychol (Paris); 1996 May; 154(2):145-6; discussion 146-7. PubMed ID: 8694403
[TBL] [Abstract][Full Text] [Related]
57. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
[No Abstract] [Full Text] [Related]
58. A placebo- and imipramine-controlled study of paroxetine.
Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
[TBL] [Abstract][Full Text] [Related]
59. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
Nemeroff CB
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
[TBL] [Abstract][Full Text] [Related]
60. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
